Andrew Lees Named to The Power List 2016

Dr. Andrew Lees, founder and Chief Scientific Officer of Fina Biosolutions, has been named to The Power List 2016 – the Top 100 most influential people in the world of drug development and manufacture.

“My most significant contribution is the development of CDAP chemistry for conjugate vaccines,” says Andrew. “CDAP is perhaps the simplest and most efficient chemistry for making conjugate vaccines. It is used by GSK in their pneumonia and meningococcal vaccines and emerging market manufacturers are using CDAP chemistry to develop more affordable conjugate vaccines.”